Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Biochemical Journal|May 19, 2000
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptidesT Tokuda, M Calero, E Matsubara, et al.
Neurologia (Barcelona, Spain)|March 7, 2008
[Usefulness of the 14-3-3 test for the diagnosis of sCJD evaluated by a Spanish reference center]N Cuadrado-Corrales, A Jiménez-Huete, C Albo, et al.
The Journal of Clinical Investigation|December 20, 2000
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrierM Shibata, S Yamada, S R Kumar, et al.
The Journal of Clinical Investigation|August 26, 1998
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayerJ B Mackic, M Stins, J G McComb, et al.
European Journal of Neurology|February 13, 2013
Reduced serum progranulin level might be associated with Parkinson's disease riskI Mateo, I González-Aramburu, A Pozueta, et al.
The Journal of Biological Chemistry|September 15, 2001
Systemic amyloid deposits in familial British dementiaJ A Ghiso, J Holton, L Miravalle, et al.
Applied and Environmental Microbiology|December 6, 2023
Genetic dissection of the degradation pathways for the mycotoxin fusaric acid in Burkholderia ambifaria T16Matias Vinacour, Mauro Moiana, Ignasi Forné, et al.
Acta Neuropathologica|July 27, 2000
Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 alleleR Vidal, M Calero, P Piccardo, et al.
Revista Clinica Espanola|January 1, 2019
Prevalence of diabetes, use of antidiabetic drugs and degree of glycaemic control in the province of Cadiz (2014-2016): A population-based studyJ Escribano Serrano, M I Méndez-Esteban, A García-Bonilla, et al.
Leukemia|October 3, 2002
Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92T M Calero Moreno, G Gustafsson, S Garwicz, et al.
Pageof 7